BioHealth News Archive
Montgomery County Moves Up in National Biopharma Rankings
Montgomery County is proving to be a premium address for the growing biotechnology sector. The BioHealth Capital Region, which includes Maryland, Virginia and Washington…
Read More(8) The Squeeze Continues…Early Stage Health Tech Deal Volume Falls to New Lows – LinkedIn
Five consecutive quarters—and counting—of declining deal counts in pre-seed and seed-level investments for health technology startups in the U.S. {iframe}https://www.linkedin.com/pulse/squeeze-continuesearly-stage-health-tech-deal-volume-falls-thomas/{/iframe}
Read MoreFall 2018 Inova Discovery Series Registration, Wed, Nov 7, 2018 at 6:00 PM
We're thrilled to announce Molly McCartin, Partner, Drive Capital, will be a featured speaker at the Fall 2018 Inova Discovery Series! Molly McCartin is…
Read MoreSparkLabs launches DC accelerator for cybersecurity and blockchain startups – Technical.ly DC
It’s cybersecurity month at Technical.ly and this new accelerator program is here to heat up the discussion. {iframe}https://technical.ly/dc/2018/10/12/sparklabs-launches-dc-accelerator-for-cybersecurity-and-blockchain-startups/{/iframe}
Read MoreWhat drives pharma m&a – McKinsey
There are lessons for other industries in the way pharma companies use mergers to innovate, work more efficiently, and bolster product portfolios. {iframe}https://www.mckinsey.com/business-functions/strategy-and-corporate-finance/our-insights/whats-behind-the-pharmaceutical-sectors-m-and-a-push?cid=other-eml-alt-mip-mck-oth-1810&hlkid=ecb68189d4104c6e9fab9262b429b597&hctky=3027237&hdpid=41bb6d4e-76bc-4a0d-bac4-5c67e2d62194{/iframe}
Read MoreAgeneBio gets grants to advance therapeutics to slow Alzheimer’s disease – Technical.ly Baltimore
Baltimore-based AgeneBio announced a pair of grants from the National Institutes of Health that will assist with clinical trials of a treatment to combat the…
Read MoreMaxCyte Begins Dosing in First Clinical Trial in Solid Tumors – American Pharmaceutical Review
MaxCyte announced the first patient has been dosed in its Phase I dose-escalation clinical trial in the United States with the company's lead wholly-owned…
Read MoreJonathan Aberman: You want funding? Follow this advice. – Washington Business Journal
However long a business has operated, investors will look for three big things if they are going to invest. {iframe}https://www.bizjournals.com/washington/news/2018/10/11/jonathan-aberman-you-want-funding-follow-this.html?ana=e_me_set2&s=newsletter&ed=2018-10-11&u=fQFLvOpMSMnvK7iAcBsVng0eb45ba2&t=1539610411&j=84341881{/iframe}
Read MoreHealthcare companies rake in $23B in venture capital funding
U.S. healthcare companies have collected $23.4 billion in venture capital funding this year — already surpassing the amount the sector obtained in all of…
Read MoreInnovation challenges are all the rage with pharma, and they’re likely here to stay: study | FiercePharma
The number of open innovation challenges in pharma grows by the day. But what’s driving them? That’s what Luminary Labs wanted to know. So…
Read MoreInaugural Investment Conference Marks Inflection Point for the BioHealth Capital Region · BioBuzz
The first Biohealth Capital Region Investment Conference kicks off this week in Montgomery County. The conference marks an important inflection point for a region…
Read MoreTop 10 European Biopharma Clusters, October 2018 – GEN
Europe’s biotech industry recently celebrated its growth and progress with more than 120 events taking place across 18 European countries September 24 –30, in…
Read MoreVC Investment Jumps 51% Year-over-Year During Q3 – GEN
Biopharma venture capital activity maintained its red-hot pace during the third quarter of 2018, driven by a handful of deals exceeding $200 million, according…
Read MoreQ&A With BeneVir Co-Founder, Katherine Sacksteder, PhD – The Path to a Landmark Acquisition (Part 1) · BioBuzz
This has been a year marked by many notable biotech deals, especially in the immunotherapy market. One deal, in particular, has generated more local…
Read More